Catalog No.
EVV19904
Expression system
Mammalian Cells
Species
Dengue virus type 3
Protein length
Arg282-Thr723
Predicted molecular weight
51.17 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
A0A3G1J4X7
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Envelope protein E
Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue., PMID:40432141
miRNome analysis reveals mir-155-5p as a protective factor to dengue infection in a resistant Thai cohort., PMID:39976655
RT-RPA Assisted CRISPR/Cas12a Based One-Pot Rapid and Visual Detection of the Pan-Dengue Virus., PMID:39949262
Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains., PMID:39700304
Dominance of dengue virus serotype-2 in Pakistan (2023-2024): Molecular characterization of the envelope gene and exploration of antiviral targets., PMID:39557198
Genetic and structural characterization of dengue virus involved in the 2023 autochthonous outbreaks in central Italy., PMID:39475407
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil., PMID:39116904
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults., PMID:38294972
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination., PMID:37909048
Genetic Characterization of the Dengue Virus Type 3 Genotype I Prevailing in Dhaka, Bangladesh, 2021., PMID:37603293
Epitope prediction and designing of receptor inhibitor of Dengue Envelope Protein: An in silico approach., PMID:37417165
Experimental Dengue Virus Type 4 Infection Increases the Expression of MicroRNAs-15/16, Triggering a Caspase-Induced Apoptosis Pathway., PMID:37367040
Isolation and Genetic Evolution of Dengue Virus from the 2019 Outbreak in Xishuangbanna, Yunnan Province, China., PMID:37184906
Evolutionary dynamics of dengue virus in India., PMID:37011104
Development of novel antiviral peptides against dengue serotypes 1-4., PMID:36739680
The dengue virus 4 component of NIAID's tetravalent TV003 vaccine drives its innate immune signature., PMID:36734144
Sensitive Zika biomarker detection assisted by quantum dot-modified electrochemical immunosensing platform., PMID:36371925
Molecular Characterization and Identification of Potential Inhibitors for 'E' Protein of Dengue Virus., PMID:35632682
Clinical Characteristics and Risk Factors for Severe Dengue Fever in Xishuangbanna, During the Dengue Outbreak in 2019., PMID:35359722
Differential heterologous neutralisation profile against strains within DENV-3 genotype II., PMID:35225194
Antiviral activity of silymarin and baicalein against dengue virus., PMID:34707245
Structural landscape of the complete genomes of dengue virus serotypes and other viral hemorrhagic fevers., PMID:34000991
Co-Circulation of All Four Dengue Viruses and Zika Virus in Guerrero, Mexico, 2019., PMID:33944623
DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model., PMID:33121347
Antibody-independent and dependent infection of human myeloid cells with dengue virus is inhibited by carrageenan., PMID:32866533
Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine., PMID:32300346
Molecular Epidemiology of Dengue Viruses Isolated in Shantou City, China, during 2015-2017., PMID:32115543
Spatio-temporal distribution analysis of circulating genotypes of dengue virus type 1 in western and southern states of India by a one-step real-time RT-PCR assay., PMID:31376506
Genotype replacement of dengue virus type 3 and clade replacement of dengue virus type 2 genotype Cosmopolitan in Dhaka, Bangladesh in 2017., PMID:31351235
Mast cell stabilizing effect of a geranyl acetophenone in dengue virus infection using in vitro model of DENV3-induced RBL-2H3 cells., PMID:31110077
Phylogenetic analysis of partial pre-membrane and envelope sequences of dengue viruses circulating in India., PMID:31002930
Tracking dengue virus type 1 genetic diversity during lineage replacement in an hyperendemic area in Colombia., PMID:30845200
In vitro analysis of synthetic peptides in blocking the entry of dengue virus., PMID:30508603
Dynamics of nonstructural glycoprotein-1 in dengue patients presenting with different clinical manifestations from 1986 to 2012 in Rio de Janeiro, Brazil., PMID:30411369
Emergence of dengue virus type 1 and type 3 as dominant serotypes during 2017 in Pune and Nashik regions of Maharashtra, Western India., PMID:30366083
Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua., PMID:30266790
Surveillance for Flaviviruses Near the Mexico-U.S. Border: Co-circulation of Dengue Virus Serotypes 1, 2, and 3 and West Nile Virus in Tamaulipas, Northern Mexico, 2014-2016., PMID:30226141
Molecular characterisation and phylogenetic analysis of dengue outbreak in Pasighat, Arunachal Pradesh, Northeast India., PMID:29735824
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo., PMID:29367852
Phylogenetic analyses of DENV-3 isolated from field-caught mosquitoes in Thailand., PMID:29126872
Neurological manifestations of dengue in Central Brazil., PMID:28700057
Complete genome analysis of dengue virus type 3 isolated from the 2013 dengue outbreak in Yunnan, China., PMID:28648850
Epidemiological and molecular characteristics of emergent dengue virus in Yunnan Province near the China-Myanmar-Laos border, 2013-2015., PMID:28482813
Gene Polymorphisms and Serum Levels of Pro- and Anti-Inflammatory Markers in Dengue Viral Infections., PMID:27336361
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies., PMID:27301568
Increasing Clinical Severity during a Dengue Virus Type 3 Cuban Epidemic: Deep Sequencing of Evolving Viral Populations., PMID:26889031
Comparison of E and NS1 antigens capture ELISA to detect dengue viral antigens from mosquitoes., PMID:26119545
Vector competence of the Aedes aegypti population from Santiago Island, Cape Verde, to different serotypes of dengue virus., PMID:25888847
Computational prediction and analysis of envelop glycoprotein epitopes of DENV-2 and DENV-3 Pakistani isolates: a first step towards Dengue vaccine development., PMID:25775090
Molecular classification of outcomes from dengue virus -3 infections., PMID:25728087
For research use only. Not for human or drug use.
